Literature DB >> 10029818

Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.

M Kalyanaraman1, S M Heidemann, A P Sarnaik, K L Meert, S A Sarnaik.   

Abstract

PURPOSE: Signs and symptoms of delayed hemolytic transfusion reaction (DHTR) may resemble those of vaso-occlusive crises in patients with sickle cell anemia (SCA). The diagnosis of DHTR therefore presents a challenge to the clinician when treating such patients. The current study describes a patient with SCA and DHTR secondary to red cell anti-s antibody, manifesting as painful extremeties, severe hemolytic anemia, and acute oliguric renal failure. PATIENTS AND METHODS: A 17-year-old patient with homozygous hemoglobin S presented 8 days after partial exchange transfusions with severe anemia and signs and symptoms resembling vaso-occlusive crisis. Clinical course was complicated by intravascular hemolysis and acute renal failure.
RESULTS: Anti-s antibody was detected in the eluate. Diagnosis of DHTR was made. Treatment included single volume whole blood exchange transfusion and continuous veno-venous hemofiltration with dialysis.
CONCLUSIONS: The possibility of DHTR should be considered in a patient with SCA with hemolytic anemia. Acute renal failure is a rare complication of anti-s antibody-associated DHTR. Such reactions can be successfully managed with exchange transfusion and continuous hemofiltration with dialysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029818

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

Review 1.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

2.  Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK(b) in intermediate β-thalassemia patient in Tabriz.

Authors:  Roya Dolatkhah; Ali Esfahani; Seyed Esmaeil Torabi; Iraj Asvadi Kermani; Zohreh Sanaat; Jamal Eivazei Ziaei; Alireza Nikanfar; Seyed Hadi Chavoshi; Zohreh Ghoreishi; Atabak Asvadi Kermani
Journal:  Asian J Transfus Sci       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.